Medical Research
(H123)
IRS Verified
DX Registered
990 on File
GOLFER VS BRAIN CANCER INC
Financial strength (30%)
50/100
Reliability (20%)
50/100
Effectiveness (25%)
43/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Now in its sixth year,Golfers Vs. Brain Cancer has raised over $250,000 to support brain cancer research, for that very purpose-to find a cure. To date, these funds have helped support ongoing research and resources to treat brain cancer patients at Moffitt Cancer Center in Tampa.
Financial Overview — FY 2023
$64K
Total Revenue
$85K
Total Expenses
$89K
Net Assets
N/A
Employees
Revenue Sources
Program Expense Ratio
0.0%
Fundraising Efficiency
48.2%
Operating Reserve
12.70x
Liability-to-Asset
0.0%
Revenue Diversification
16.8%
Compared with Peers
FY 2023
Compared with 1,152 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
0.0% | 80.3% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
48.2% | 39.4% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
12.7 mo | 37.0 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
16.8% | 100.0% |
P10P90
|
Top quarter |
|
Surplus margin
Surplus as a share of revenue
|
-33.0% | 12.7% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $64K | $85K | $89K | 0.0% | — |
| 2021 | $95K | $881 | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.